Jason Baum
Impact in
Papers in
- Oncology 18
- Cancer Immunotherapy and Biomarkers 9
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 3
-
- Glycosylation and Glycoproteins Research 4
- Co-authors
- Kimberly McCall (4 shared papers)Hermann Steller (1 shared paper)Eli Arama (1 shared paper)Jeanne S. Peterson (2 shared papers)Alexey A. Lugovskoy (9 shared papers)Ulrik B. Nielsen (6 shared papers)Birgit Schoeberl (5 shared papers)Sharlene Adams (7 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Molecular Cancer Therapeutics (4 papers)Clinical Cancer Research (3 papers)Cancer Research (3 papers)Journal of Thoracic Oncology (2 papers)
- Partner nations
- United StatesSouth KoreaChina
In The Last Decade
Jason Baum
30 papers receiving 677 citations
Peers
Comparison fields: 5 of 81
- Aging 30
- Oncology 240
- Immunology 144
- Molecular Biology 347
- Radiology, Nuclear Medicine and Imaging 104
Countries citing papers authored by Jason Baum
This map shows the geographic impact of Jason Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Baum more than expected).
Fields of papers citing papers by Jason Baum
This network shows the impact of papers produced by Jason Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Baum. The network helps show where Jason Baum may publish in the future.
Co-authors
The 25 scholars most cited alongside Jason Baum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 113 | |
| 2 | 2003 | 100 | |
| 3 | 2013 | 89 | |
| 4 | 2007 | 70 | |
| 5 | 2020 | 69 | |
| 6 | 2019 | 61 | |
| 7 | 2018 | 46 | |
| 8 | 2013 | 23 | |
| 9 | 2024 | 16 | |
| 10 | Auranofin therapy for juvenile rheumatoid arthritis: results of the five-year open label extension trial. | 1991 | 12 |
| 11 | 2021 | 11 | |
| 12 | 2023 | 10 | |
| 13 | 2016 | 10 | |
| 14 | 2022 | 10 | |
| 15 | 2019 | 7 | |
| 16 | 2004 | 7 | |
| 17 | 2020 | 5 | |
| 18 | 2016 | 5 | |
| 19 | 2015 | 4 | |
| 20 | 2012 | 4 |
About Jason Baum
Jason Baum is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 30 papers that have together received 690 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), HER2/EGFR in Cancer Research (5 papers), Glycosylation and Glycoproteins Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Lung Cancer Treatments and Mutations (4 papers), Gastric Cancer Management and Outcomes (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Aging (30 citations), Oncology (240 citations), Immunology (144 citations), Molecular Biology (347 citations) and Radiology, Nuclear Medicine and Imaging (104 citations). Jason Baum has collaborated with scholars based in United States, South Korea and China. Frequent co-authors include Kimberly McCall, Hermann Steller, Eli Arama, Jeanne S. Peterson, Alexey A. Lugovskoy, Ulrik B. Nielsen, Birgit Schoeberl, Sharlene Adams, Bryan W. Johnson and Sergio Iadevaia. Their work appears in journals such as Journal of Clinical Oncology, Molecular Cancer Therapeutics, Clinical Cancer Research, Cancer Research and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.